S. Reshwan K. Malahe

The RECOVAC Immune-response Study: The Immunogenicity, Tolerability, and Safety of COVID-19 Vaccination in Patients With Chronic Kidney Disease, on Dialysis, or Living With a Kidney Transplant

Jan‐Stephan Sanders, Fréderike J. Bemelman, A. Lianne Messchendorp et al. · Transplantation · 2021 · 189 citations · Full text

The RECOVAC Immune-response Study: The Immunogenicity, Tolerability, and Safety of COVID-19 Vaccination in Patients With Chronic Kidney Disease, on Dialysis, or Living With a Kidney Transplant.

Jan‐Stephan Sanders, Fréderike J. Bemelman, A. Lianne Messchendorp et al. · PubMed · 2022 · 121 citations · Full text

Clinical Characteristics and Outcomes of Immunocompromised Patients With Coronavirus Disease 2019 Caused by the Omicron Variant: A Prospective, Observational Study

S. Reshwan K. Malahe, Rogier A.S. Hoek, Virgil A. S. H. Dalm et al. · Clinical Infectious Diseases · 2022 · 83 citations · Full text

Alternative strategies to increase the immunogenicity of COVID-19 vaccines in kidney transplant recipients not responding to two or three doses of an mRNA vaccine (RECOVAC): a randomised clinical trial

Marcia M. L. Kho, A. Lianne Messchendorp, Sophie C. Frölke et al. · The Lancet Infectious Diseases · 2022 · 68 citations · Full text

Vaccinology, Vaccination, Transplantation +11

Post COVID-19 condition imposes significant burden in patients with advanced chronic kidney disease: A nested case-control study

Pim Bouwmans, S. Reshwan K. Malahe, A. Lianne Messchendorp et al. · International Journal of Infectious Diseases · 2024 · 15 citations · Full text

Post Covid-19 Condition, Covid-19 Epidemiology, Covid-19 +16